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Abstract
Background: Opt-out HIV testing is a novel concept in Australia. In the opt-out approach, health care providers
(HCPs) routinely test patients for HIV unless they explicitly decline or defer. Opt-out HIV testing is only performed
with the patients’ consent, but pre-test counselling is abbreviated. Australian national testing guidelines do not
currently recommend opt-out HIV testing for the general population. Non-traditional approaches to HIV testing
(such as opt-out) could identify HIV infections and facilitate earlier treatment, which is particularly important now
that HIV is a chronic, manageable disease. Our aim was to explore HCPs’ attitudes toward opt-out HIV testing in an
Australian context, to further understanding of its acceptability and feasibility.
Methods: In this qualitative study, we used purposeful sampling to recruit HCPs who were likely to have
experience with HIV testing in Western Australia. We interviewed them using a semi-structured guide and used
content analysis as per Graneheim to code the data. Codes were then merged into subcategories and finally
themes that unified the underlying concepts. We refined these themes through discussion among the research
team.
Results: Twenty four HCPs participated. Eleven participants had a questioning attitude toward opt-out HIV testing,
while eleven favoured the approach. The remaining two participants had more nuanced perspectives that
incorporated some characteristics of the questioning and favouring attitudes. Participants’ views about opt-out HIV
testing largely fell into two contrasting themes: normalisation and routinisation versus exceptionalism; and a need
for proof versus openness to new approaches.
Conclusion: Most HCPs in this study had dichotomous attitudes toward opt-out HIV testing, reflecting contrasting
analytical styles. While some HCPs viewed it favourably, with the perceived benefits outweighing the perceived
costs, others preferred to have evidence of efficacy and cost-effectiveness.
Background
Opt-out HIV testing is a novel concept in Australia. In
the opt-out approach, health care providers (HCPs) rou-
tinely test patients for HIV unless they explicitly decline
or defer. Opt-out HIV testing is only performed with the
patients’ consent, but pre-test counselling is abbreviated
[1]. This approach to HIV testing uses the behavioural
economics concept of default bias, which is the propen-
sity to choose inaction over action [2, 3] Australian na-
tional testing guidelines do not currently recommend
opt-out HIV testing for the general population. HIV
testing in Australia is “opt-in”, which means that testing
is conducted according to risk factors (such as sexual or
drug use practices), clinical indication (such as having
another sexually transmitted infection), or by patient
request [1]. However, there has been a recent increase in
HIV infections in Australia, with the highest number of
HIV diagnoses in 20 years recorded in 2013 [4]. In
addition, up to 50 % of patients diagnosed with HIV have
already developed immune deficiency [4]. An Australian
study showed that over half of the people with HIV sought
health care in the year prior to their diagnosis [5] which
indicates that opportunities to test patients for HIV are
being missed. Non-traditional approaches to HIV testing
(such as opt-out) could identify HIV infections and facili-
tate earlier treatment, which is particularly important now
that HIV is a chronic, manageable disease [6, 7]. Opt-out
testing approaches to other sexually transmitted infections
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like chlamydia, gonorrhoea, and hepatitis B have been
found to be cost-effective and acceptable to patients
[8–10]. Experimental research has shown that opt-out test-
ing is particularly effective in increasing testing rates and
patient acceptance of stigmatised diseases such as HIV [11].
Results published in systematic reviews have shown
that opt-out HIV testing is generally acceptable to HCPs
[12–14]. However, these reviews were conducted in set-
tings that may not be generalizable to Australia, such as
low-and middle-income countries [12] or sub-Saharan
Africa [13]. One systematic review of HIV testing in
resource-rich countries included three Australian studies,
but these studies did not address the opt-out approach or
testing in the general population [14]. A US systematic re-
view addressed operational aspects of opt-out HIV testing,
which may not be transferable to the Australian context
due to differences between the countries’ health systems
[15]. A review of opt-out HIV testing in Australian ante-
natal clinics suggested that it was effective (expectant
mothers are the only group in which opt-out HIV testing
is recommended in Australia), but it may not be applic-
able to the general Australian population [16]. Despite the
plethora of international research on the topic, it is not
known to what extent opt-out HIV testing is appropriate,
acceptable, or feasible to HCPs in general health care
settings in Australia. Two Australian studies indicated that
educational barriers (such as a lack of HIV content during
training) and operational barriers (such as time con-
straints) prevent Australian HCPs from seeing HIV as
relevant to their practice. Informants also stated that
Australian general practitioners should make HIV testing
a routine part of their practice [17, 18].
Acceptability and feasibility of the opt-out approach to
HIV testing should be thoroughly explored from an
HCP perspective before considering a change in testing
practice. Diagnostic testing differs from other health
interventions because only physicians (or other qualified
HCPs) are legally permitted to order and receive finan-
cial reimbursement for tests. Fundamentally, every HIV
test is the end result of an HCP’s decision-making
process, which is affected by his or her attitudes, know-
ledge, experience, and training; and is influenced by
colleagues, professional organisations, health systems,
and financial incentives. This means that a change in
HIV testing practice cannot occur without exploring the
attitudes that influence HCPs’ decision-making pro-
cesses. Our aim was to explore HCPs’ attitudes toward
opt-out HIV testing in an Australian context, to further
understanding of its acceptability and feasibility.
Method
Participants
We conducted this qualitative research in Western
Australia. Using purposeful and snowball sampling, we
recruited participants who were likely to have experience
with HIV testing [19]. The sample included primary care
nurse practitioners (NPs), general practitioners (GPs),
and physician specialists in relevant fields (such as pub-
lic health) who perform HIV testing in their practice.
Among these participants, we chose a variety of ages,
settings, and years in practice, to enhance data richness
and diversity. We estimated that 20–25 participants
would be required to reach data saturation. Between
April and November 2014, one researcher (SL) conduc-
ted the interviews using a semi-structured guide [see
Additional file 1]. Sampling continued until data satur-
ation was reached. This study was approved by the Hu-
man Research Ethics Committee at Curtin University. All
participants gave written consent to be interviewed.
Data analysis
The interviews were audio-recorded and transcribed ver-
batim. After transcription we read each transcript sev-
eral times for data immersion. Using content analysis as
described by Graneheim, one researcher (SL) coded the
transcripts, which involved placing words or segments of
text into categories based on consistency of meaning
[20]. Next, the transcripts were independently coded by
an experienced qualitative researcher (RM) to enhance
the codes’ reliability. We then refined the codes through
discussion and frequent review of the raw data to find
supporting evidence for each code, which was an itera-
tive process that took place over several months [21].
We then combined the codes into subcategories based
on similarity of meaning, which we then merged into
themes that unified the underlying concepts. We refined
these themes through discussion among the research
team, and conducted four member checks to confirm
theme validity and enhance rigor [22]. We used NVivo
software to organise the qualitative data.
Results
We conducted 24 semi-structured interviews. The age of
the participants ranged from 31 to 66, with a mean age
of 43 years (median = 43; SD = 8.7). Forty-one percent
(N = 10) of the participants were female. The mean
number of hours per week the participants spent in clin-
ical practice was 28.7 (median = 32.5; SD = 14.8). Seven-
teen participants were GPs, five were NPs, and two were
physician specialists. The number of years since com-
pleting general practice or specialty training (or masters’
level training for NPs) ranged from one to 43, with a
mean of 13.5 years (median = 10, SD = 11.3). Whilst par-
ticipants were often unsure, the number of estimated
HIV tests they had ordered in the previous year ranged
from zero to 1000. Similarly, the number of HIV-
positive diagnoses participants estimated to have made
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over the course of their career ranged from zero to 100.
(See Table 1).
We present two findings that emerged from the data.
Participants’ views about opt-out HIV testing largely fell
into two contrasting themes: normalisation and routin-
isation versus exceptionalism; and a need for proof ver-
sus openness to new approaches. Eleven participants
had a questioning attitude toward opt-out HIV testing,
while eleven favoured the approach. The remaining two
participants had more nuanced perspectives that in-
corporated characteristics of both the questioning and
favouring attitudes. See Fig. 1.
Exceptionalism vs normalisation and routinisation
Exceptionalism
Exceptionalism refers to the belief that HIV testing is
different from other chronic disease testing [23, 24]. Ac-
cordingly, some participants stated that HIV testing was
not as relevant, appropriate, or applicable as testing for
or preventing other diseases. They saw it as being differ-
ent from other conditions. One participant explained the
clinical decision making process:
What’s my idea with this patient? I’ve got to manage
the diabetes. Try and get him to stop smoking and
prevent cardiovascular disease. Should I test him for
HIV? No, probably not. (Participant 10, GP)
Exceptionalism was sometimes based on the partici-
pants’ belief that due to patient characteristics or socio-
economic status, their patient population was not at risk
of HIV. These HCPs felt they were able to profile their pa-
tients’ behaviour, which was underpinned by assumptions.
In the last 12 months, the majority of my practice was
one in which the population generally doesn’t have
at-risk type behaviours–it’s an established upper
middle class background so it’s a relatively low
proportion. (Participant 11, GP)
Other examples of HIV exceptionalism related to pre-
test counselling and prevention education, which are not
required for other common medical tests.
To me the money would be better off increasing
the awareness of risk factors rather than
spending money on testing every single person.
There’s no point in testing a nun, for example.
(Participant 21, NP)
Some participants stated that the recent increase in
local HIV diagnoses indicated a need for more HIV pre-
vention education, or a need for increased awareness,
not a new testing protocol with abbreviated pre-test
counselling. Similarly, condensing pre-test counselling
would mean that an opportunity to educate people about
HIV prevention could be missed.
I know that there’s a high risk background for many
of our clients, there’s needle sharing and risk-taking
behaviour, but I don’t want [opt-out HIV testing] to
replace education. The recent HIV statistics show that
it’s the younger population or heterosexual population,
people that are coming back from overseas…I think
that’s where education has failed rather than
[indicating a need to] have everybody tested. If you
miss the dialogue then you miss an opportunity.
(Participant 1, GP)
Another aspect of HIV exceptionalism was the concept
of stigma. Six participants who expressed discomfort with
opt-out testing had beliefs about HIV that suggested they
considered an HIV diagnosis a stigma. One participant
indicated discomfort with the patient behaviours that led
to HIV transmission:
And you’d be surprised that plenty [of patients] admit
to things that you just think, how could they?
(Participant 18, GP)
This discomfort with the sexual and drug use behav-
iours that could transmit HIV indicated that this partici-
pant would not routinely suggest HIV testing during
patient consultations.
Table 1 Participant characteristics





Specialty physician 2 (8.3)
Mean (SD)
Age (years) 43.8 (8.7) 31–66
Median
Years since specialty training
completion
10 1–43
Hours worked per week 32.5 0–42.5
Estimate of HIV tests performed in
preceding year
49 0–1000
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Specialist HCPs frequently mentioned GPs’ lack of up-
to-date knowledge about HIV epidemiology, possibly
related to its historic association with men who have sex
with men, a stigmatised group.
GP’s perceptions on the type of person that has HIV,
which are inaccurate considering the large amount of
heterosexual transmission in Australia, might not have
caught up yet. (Participant 22, GP)
This suggests that stigmatizing beliefs about HIV pre-
vent GPs from considering testing people from other
populations.
Another example of exceptionalism was the concern
among some participants that opt-out HIV testing would
cause excessive patient anxiety.
I don’t think it’s a good idea to screen almost everyone
like that. I don’t think that it would be very useful. It
might trigger unnecessary anxiety and worries.
(Participant 16, NP)
Two participants mentioned potential for suicide as a
possible patient response to an HIV-positive result, caus-
ing them to limit HIV testing to special appointments
that allowed extra time for patient counselling.
It could lead to suicides and so with the
anxiety, you’re going to need longer appointments
for somebody who’s coming for HIV testing.
(Participant 12, GP)
Any screening or diagnostic test can cause patient
anxiety, but the participants’ degree of concern indicated
that for them, HIV was unlike testing for other diseases
and required special procedures.
Normalisation and routinisation
Normalisation in HIV testing refers to offering testing
in the same way for HIV as for as other medical tests
for less stigmatised diseases. Despite the relatively low
likelihood of finding an HIV-positive result, these par-
ticipants believed that preventing late diagnosis was a
benefit of the opt-out method.
Lots of people are going to be negative and
[there would] be just the odd positive one and
you’d probably increase their life span by catching
that person, so they’re not going to fall in a big
heap in ICU with an AIDS-defining illness.
(Participant 7, GP)
Compared with HCPs who tended to question
opt-out HIV testing, those favouring it tended to
present HIV testing as a normal clinical activity,
similar to testing for other chronic conditions (such as
diabetes).
I just don’t see HIV any different to any other
long-term disease. Every time I test someone for
blood sugar levels I don’t go on and on about
how awful the disease diabetes is, you know?
(Participant 21, NP)
Fig. 1 Concept map of themes
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This participant stated that normalising HIV testing
with the opt-out approach could decrease stigma, which
could have broader societal benefits.
I’m working in a sexual health clinic and essentially I
offer it to everybody without taking regard of classic
risk factors. We already have a slightly higher risk
group and also I just don’t think there’s any reason not
to test for HIV. We’re never going to get rid of the
stigma around HIV unless we treat it like everything
else. (Participant 7)
Routinisation is similar to normalisation but refers to
testing according to a standardised protocol or proced-
ure, as opposed to testing according to clinical indica-
tion or risk factor [25]. Opt-out HIV testing would be
akin to measuring adult patients’ blood pressure at every
consult—a routine practice regardless of whether the pa-
tient has risk factors for high blood pressure or requests
the test. In our study, participants who favoured opt-out
HIV testing incorporated it into routine practice, rather
than viewing it as an exceptional clinical event. As this
participant indicates, making HIV testing a routine part
of practice reassures patients that they are not being sin-
gled out.
It makes it a routine and acceptable thing–the same
as we would say, for every pregnant person we always
check to make sure you don’t have chlamydia, to make
sure your blood group, etc., and it normalises it to say
there’s nothing good, bad or indifferent about being
HIV positive. It just means it’s better to know than to
not. (Participant 24, specialist physician)
Proof vs openness
Proof
Ten of the 11 participants who had a questioning atti-
tude toward opt-out HIV testing cited a lack of rationale
or evidence for a change in testing strategy. In their
view, opt-out HIV testing would be reasonable only if
there was risk factor-based evidence to support it.
I think if there was an evidence base to say,
this particular population have x number of risk
factors, then [an] opt-out test should be offered,
then I think that would be completely reasonable.
(Participant 11, GP)
Some referred to evidence-based practice concepts
such as statistical significance, pre-test probability, and
survival rates, like this participant:
I would question the premise of offering HIV testing to
everyone. If we’re going to offer a group of people a
battery of tests, there has to be good evidence that
we’re going to find that disease in that population.
If you can prove that you’re going to pick up new
infections at a statistically significant rate and
prevent adverse outcomes and improve treatment and
survival rates, then it’s a reasonable thing to do.
(Participant 14, GP)
Some comments indicated a lack of knowledge about
the high sensitivity and specificity of current HIV tests,
overestimating the risk of a false positive result, such as
this GP:
I personally would refuse to be tested because I don’t
want to deal with false positives–it will have some
anxiety related to it until you get the results back.
(Participant 18, GP)
This participant did not mention the demonstrated
benefits of early HIV diagnosis, and seemed skeptical
that knowing one’s HIV status could be a positive effect
of increased testing.
I’d like to see the evidence first [about] the benefit,
that every single person in the country knows their
HIV status. If we tested every single person for HIV,
I’d like to know how many more people we are picking
up that we’re missing. I’d like to know if early
diagnosis reduces complications afterwards.
(Participant 21, NP)
Need for proof was often framed in terms of cost-
effectiveness. Participants stated that if HIV testing were
increased, more beneficial health interventions could be
neglected.
You’d need to look at whether or not the number of
new diagnoses you made is worth the cost or whether
your portion of health money could go into something
else that would be potentially more valuable.
(Participant 3, GP)
Need for proof was also associated with a fear of
reprimand. Participants indicated that if they performed
more HIV tests, Australian government funding bodies
(Medicare) would question its appropriateness.
Medicare would be tapping on my door asking why
I’m doing so many HIV tests, and can I justify the
expense to the government? (Participant 24, GP)
The need for proof of concept was seen as important to
protect HCPs delivering what they perceived to be poten-
tially contentious care.
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Openness to new approaches
Openness to new testing approaches was a common
attitude among participants who favoured opt-out HIV
testing. Participants often referred to the benefits of in-
creased HIV testing and mentioned positive outcomes
from other countries. One participant stated that opt-out
testing could prompt HCPs to test more patients for HIV.
So, I think it’s a good thing to have and it just makes
us think about us doing it more as opposed to thinking
about doing it less. (Participant 6, NP)
This participant was aware of evidence about opt-out
HIV testing from other countries and considered its
implications for her practice:
I think that it’s being shown in countries like England
around the pregnancy testing and I think it is
dangerous when people do their own risk assessment.
And what they found in England is that obstetricians
got it wrong. (Participant 23, GP)
Unlike the HCPs who had a more questioning attitude
toward opt-out HIV testing, participants who were open
to the approach thought that the cost of opt-out HIV
testing was reasonable and would be acceptable to the
public.
To me it seems a well-run, well-managed process…it’s
not a massive cost on the public purse that people get
agitated about. (Participant 8, GP)
This participant advocated expanding opt-out testing
to the emergency department to expand access to HIV
testing:
You could do it in EDs, you could do it in other
settings where there’s a much bigger throughput. [ED]
might not be a bad spot to target because they’re
seeing a cross sections of people that wouldn’t usually
access health services. (Participant 7, GP)
Discussion
This initial study of Australian HCPs’ views on opt-out
HIV testing revealed new insights and some surprise
findings. The majority of participants’ views fell into one
of two mutually exclusive categories: favouring or ques-
tioning. Participants who tended to question opt-out
HIV testing doubted its relevance to Australia, focused
on the method’s flaws, and emphasised potentially nega-
tive consequences. Surprisingly, they did not identify some
of the barriers to opt-out HIV testing that commonly
appeared in previous research, such as operational issues
[15, 26, 27], time constraints [28–30] or inadequate
linkage to HIV care [31]. Conversely, participants who
were generally comfortable with opt-out HIV testing had
similar views to those identified in previous research, such
as placing HIV testing in the same domain as testing for
other diseases [27, 31]. Finally, pilot studies provide useful
data about changes in clinical practice before wider imple-
mentation, but participants in this study did not suggest a
pilot test of opt-out HIV testing in an Australian setting.
Participants who had a questioning attitude toward
opt-out HIV testing doubted its relevance to the general
Australian population, citing a lack of evidence for effi-
cacy in lower prevalence populations. Australia has a
low HIV prevalence by global standards; however, the
idea that HIV testing is irrelevant in areas with low rates
of infection has been considered the “false security” of
low prevalence [29] (p.75), potentially resulting in de-
layed HIV diagnosis. Participants in this category stated
they were able to accurately determine which patients
should be tested based on their characteristics (such as
age or suburb of residence), a strategy that previous
studies have shown to be ineffective in identifying HIV
infections [5, 32–34]. Opt-out HIV testing could de-
crease the potential for error in patient risk assessment.
Participants who questioned the opt-out approach to
HIV testing tended to focus on its potential flaws, which
may reflect HCPs’ analytical style [35–39]. While HCPs
are trained to look for logical negatives (for instance,
they might ask themselves, “what is wrong with this pic-
ture?” in the diagnostic process), this frame of mind
could lead to pessimism about changes in practice [40].
Studies have shown that HCPs are particularly reluctant
to change their practice in view of new evidence [35]
and are prone to “paralysis by analysis”—which occurs
when the discussion about a change becomes so arduous
that no action is taken [41]. Our data also suggest that
HCPs sometimes make decisions about HIV testing
based on personal beliefs and values, not necessarily
logical reasoning, which is consistent with behavioural
economic theory [42]. A change in HIV testing practice
should take into account these common HCP analytical
patterns. A small, incremental trial should provide feasi-
bility data that could be used to determine the efficacy
of opt-out HIV testing, without ‘forcing’ HCPs into a
major change too quickly [43].
Some HCPs seemed to need more support and educa-
tion about HIV testing and disclosure of results. Partici-
pants who viewed opt-out HIV testing less favourably
were worried about potential negative consequences,
such as stigma, anxiety and suicide, supporting previous
research findings [29, 31, 44, 45]. Studies have shown
that HCP education can facilitate implementation of
opt-out HIV testing (which would be especially import-
ant in Australia, given that many participants in this
study had limited knowledge of, or experience with, the
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approach) [46]. Academic detailing (brief, one-on-one
education sessions) prior to large-scale implementation
of opt-out HIV testing has been shown to increase its
acceptance among HCPs [47]. Peer-based education
could be particularly effective because it provides a
social reference for HCPs (who are often unconsciously
influenced by their peers) [48, 49]. Because many partici-
pants in our study were worried about disclosing HIV-
positive results, HCPs should receive education about
best practices for disclosure, ideally with a protocol for
linkage to HIV care already in place [14, 45, 50]. Educa-
tion programs have also been shown to promote positive
HCP attitudes toward opt-out HIV testing, with HCPs
citing patient behaviour change and reduced HIV trans-
mission as affirming aspects of the approach [31, 51].
Although they tended to disapprove of opt-out HIV
testing for the general Australian population, partici-
pants who had a questioning attitude had flexible beliefs:
they were not necessarily opposed to opt-out HIV test-
ing, provided there was Australian evidence of efficacy
and cost-effectiveness. They were willing to revise their
attitudes based on new information or experience, which
has been associated with increased acceptance of opt-out
HIV testing [32]. Research about opt-out HIV testing has
shown that ongoing quality improvement activities (par-
ticularly with HCP participation) are essential for making
changes in practice [52]. Similarly, knowledge translation
studies have demonstrated the importance of short-term,
small-scale pilot tests before expanding new programs
[53]. Surprisingly, regardless of whether they were com-
fortable with opt-out HIV testing, participants in this
study did not suggest short-term trials or small-scale qual-
ity improvement projects before considering broader
implementation.
Few participants who were comfortable with opt-out
HIV testing mentioned its cost, indicating that for them,
potential benefits of the approach outweighed the costs.
There is scant international evidence about HCP views
on the cost of opt-out HIV testing. Further, most studies
on opt-out HIV testing were conducted in the US and
funded by federal grants, which may account for the lack
of cost concerns among US participants [53]. Future
research should explore HCP attitudes about the cost of
opt-out HIV testing and their effects on changes in test-
ing practice.
This study has provided an initial insight into the
acceptability of opt-out HIV testing in Australia. While
some HCPs have embraced the opt-out approach, risk
factor-based HIV testing remained entrenched among
some participants. Subsequent research could best in-
form future HIV testing recommendations by addressing
the issues raised by the HCPs who viewed opt-out HIV
testing less positively [54]. Given some participants’
concerns about over-testing and excessive cost, existing
Australian cost-effectiveness modelling data should be
more widely disseminated and replicated [55]. Efficacy
and feasibility data about opt-out HIV testing through a
pilot study in an Australian context could meet HCPs’
need for evidence [32]. Finally, Australian research on
opt-out HIV testing should explore the operational bar-
riers (such as time constraints) identified in international
research.
Methodological considerations
Our results should be interpreted within their methodo-
logical context. The interviews were conducted by a
clinician-researcher (SL) who had experience with opt-
out HIV testing in the US (where the opt-out approach
has been recommended for nearly a decade). During the
interviews, the participants sometimes asked the re-
searcher questions about opt-out HIV testing in the US,
which was a diversion from the aim of the research, and
may have influenced their views (but also supported
their need for education). Although we actively recruited
participants with negative or differing opinions about
opt-out HIV testing, the sampling method may have
resulted in a limited spectrum of perspectives. Due to
the small sample size, we were not able to make separate
subgroup analyses within the sample, such as a compari-
son of attitudes between HCPs with different levels of
experience. Another limitation was that the participants
practiced in one Australian state, which may not repre-
sent the full range of Australian HCPs’ views.
Conclusion
Most HCPs in this study had dichotomous attitudes
toward opt-out HIV testing, reflecting contrasting ana-
lytical styles. While some HCPs viewed it favourably,
with the perceived benefits outweighing the perceived
costs, others preferred to have evidence of efficacy and
cost-effectiveness. In response to the findings from this
study, we have designed a pilot test of opt-out HIV test-
ing in an Australian general practice. The pilot test will
explore HCP and patient experiences with the opt-out
approach, compare the number of HIV tests and results
between opt-out and traditional testing, and analyse the
cost impact of opt-out testing. Findings from this pilot
test should help to inform the desirability of introducing
opt-out HIV testing in Australia.
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